medline.ch Onkologie Gynäkologische Tumoren

	Per- and polyfluoroalkyl substances and the risk of thyroid and breast cancer: Evidence from a meta-analysis and computational toxicology. Toxicol Appl Pharmacol Shen HY, Jin MH, Wu ZC, He TT, Gao CJ. PMID: 42392276 [PubMed - as supplied by publisher]
	Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data. Gynecol Oncol Roller L, Zhou N, Atre I, Xiong N, Li J, Cheng SC, Liu N, Lacad D, Adjei M, Matulonis UA, Konstantinopoulos PA, Liu JF, Tayob N, Stover EH, Shinagare AB. PMID: 42391853 [PubMed - as supplied by publisher]
	piR-hsa-8111406 promotes proliferation and serves as a novel biomarker for early detection of ovarian cancer: a multi-center retrospective study. Int J Gynecol Cancer Lou X, Wu Y, Fu Y, Liang S, Li Y, Li K, Xu D, Wu Y, Wang Y, Du Z, Fang H, Cui W. PMID: 42391800 [PubMed - as supplied by publisher]
	Corrigendum to: Vitamin D status and breast cancer in Saudi Arabian women: case-control study [Am J Clin Nutr 98 (2013) 105-110]. Am J Clin Nutr Yousef FM, Jacobs ET, Kang PT, Hakim IA, Going S, Yousef JM, Al-Raddadi RM, Kumosani TA, Thomson CA. PMID: 42392199 [PubMed - as supplied by publisher]
	Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE. J Natl Cancer Inst Crew KD, Anderson GL, Arnold KB, Dzingle S, Michel A, DeLucie M, Law CW, Pruthi S, Sandoval Leon AC, Shirley R, Grosse Perdekamp MT, Colonna SV, Krisher SL, King TA, Yee LD, Ballinger TJ, Braun-Inglis C, Mangino DA, Wisinski KB, DeYoung CA, Ross M, Floyd JD, Kaster A, VanderWalde LH, Saphner TJ, Zarwan C, Lo S, Graham C, Conlin AK, Yost Butler K, Agnese DM, Jernigan C, Hershman DL, Neuhouser ML, Zell JA, Arun B, Kukafka R. PMID: 42391096 [PubMed - as supplied by publisher]
	Decoding PARP roles in breast cancer therapy resistance. Mol Biol Rep Abohassan M, Altalbawy FM, Jabir MS, Hasan TF, Kyada A, Nathiya D, Kaur P, Kumar MR, Abosaoda MK, Iqbal MS. PMID: 42390770 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Impact of Surgical Delay on Breast Cancer Prognosis: Systematic Review and Meta-Analysis. Ann Surg Oncol Gervais C, Brouillette K, Benzouak T, Altuntur SK, Prakash I, Wong SM, Meterissian S. PMID: 42390668 [PubMed - as supplied by publisher]
	Pregnancy-Associated Breast Cancer: A Trimester and Subtype Based Clinical Decision Framework for the Surgeon and Surgical Trainee. Ann Surg Oncol Venkatesh H, Castro Gierach G, Kanzaki L, Ali A, Williams R, Nagel S, Sarma R, Tee M, Chu Q. PMID: 42390665 [PubMed - as supplied by publisher]
	VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer. Cancer Immunol Res Huo C, Zhao X, Ye D, Lin S, Xu D, Pang SW, Xu M, Chen J, Huang C, Liu Y, Cheng A, Yang L, Lin Z, Wang L, Li B, Lu H. PMID: 42390478 [PubMed - as supplied by publisher]
	Systematic Review and Meta-Analysis: Association Between Circulating and Tissue Levels of Selenium and Zinc and Breast Cancer Risk. Breast J Lucarelli AP, Martins MM, Teruya MM, Yauti TT, Hayashi DR. PMID: 42390038 [PubMed - indexed for MEDLINE]
	Cost-effectiveness and budget impact of breast cancer genetic profiling in Egypt. Ecancermedicalscience Kotb A, Hassan WA. PMID: 42389563 [PubMed]
	Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: a prospective observational study. Ecancermedicalscience Sable S, Wadasadawala T, Kannan M, Sarin R, Pathak R, Krishnamurthy R, Gulia S, Joshi S, Popat P, Shet T. PMID: 42389560 [PubMed]
	Editorial: Immune-related biomarkers in skin and breast cancer: innovations in immunological diagnostics and therapies. Front Immunol Mallardo D, Ottaviano M, Palmieri G, Melucci MT. PMID: 42389541 [PubMed - in process]
	Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways. J Pharm Anal Zhou C, Sarian MN, Tong X, Han R, Anasamy T, Hamezah HS. PMID: 42389487 [PubMed]
	Immunocyte senescence: A new perspective on the remodeling of the ovarian cancer microenvironment and therapeutic intervention. J Pharm Anal Li X, Li X, Ni S, Zhang X, Liu B. PMID: 42389486 [PubMed]
	Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review. Cureus Mady R, Tafazal H, Soliman H, Ramadan A, Hajaj M. PMID: 42388957 [PubMed]
	Utility of preoperative outcomes of nutritional evaluation in patients with newly diagnosed ovarian cancer. Gynecol Oncol Rep Mokshagundam S, Bethurum SS, Kleinberg KA, Mahoney MR, Brown AJ, Prescott LS. PMID: 42388720 [PubMed]
	The long road after breast cancer: survivorship issues and long-term treatment effects in young women. Front Oncol Pagliuca M, Buonaiuto R, Verrazzo A, Parola S, Tafuro M, Calderaio C, Martinelli C, Di Rienzo R, Pirolo M, Zurlo C, Tinelli O, Valente R, Cirillo L, Autiero M, D'Aulisio Garigliota ML, Di Monda R, De Angelis C, De Laurentiis M. PMID: 42388620 [PubMed]
	Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Cancer Diagn Progn Sisca L, Polito MG, Iuliani M, Tonini G, Pantano F. PMID: 42388582 [PubMed]
	How BI-RADS v2025 Helps Patients: New Audits and Method of Detection. Korean J Radiol Eby PR, Cohen EO. PMID: 42388095 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 331553

Seite 1 von 16578

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung